DGUOK and lung adenocarcinoma: Although DDI as an anti‐cancer agent in Lewi's lung cancer allograft model was only modestly effective, it is possible that more potent and specific DGUOK inhibitors based on these anti‐HIV nucleotide analogs could be developed as therapeutics for lung adenocarcinoma patients.